Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-02, Stock:JNJ, The news for the past five days is as follows:
2020-05-26: NEWS1: Jim Cramer: We Have a Rip Snorting Rally Unfathomable 2 Months Ago.NEWS2: Novavax expects COVID-19 vaccine trial results in July.NEWS3: Hedge Funds Started Cashing Out Of Johnson & Johnson (JNJ) During The Crash.NEWS4: Is Abbott Stock A Buy As Coronavirus Test Accuracy Called Into Question?.NEWS5: The Zacks Analyst Blog Highlights: Bristol-Myers, Roche, AstraZeneca, Merck and Johnson & Johnson.NEWS6: Is Johnson & Johnson Stock A Buy As Pressure Mounts For A Coronavirus Vaccine?.NEWS7: 3 Dividend Stocks Ideal for Retirees.NEWS8: The More Covid-19 Vaccines, the Merrier.NEWS9: Merck leaps into COVID-19 development fray with vaccine, drug deals.
2020-05-27: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: CNBC’s Jim Cramer says a quick recovery is ‘tough to bet on’ — so here are the stocks he’s recommending.NEWS3: 5 Dividend Kings to Buy and Hold Forever.
2020-05-28: NEWS1: ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic'.NEWS2: Dow climbs 69 points on gains in shares of Boeing, Merck.NEWS3: A $39B Stock Fund Puts Dividends in Perspective During the Coronavirus Crisis.NEWS4: Is Johnson and Johnson Stock a Buy?.
2020-05-29: NEWS1: Alan Fournier Adds 4 Stocks to Portfolio.NEWS2: J&J's Ebola vaccine wins EU regulatory panel backing.NEWS3: European agency panel recommends approval of J&J's Ebola vaccine.
2020-06-01: NEWS1: It was a relatively easy decision: J&J Exec shares experience working in the frontlines.NEWS2: Best Dividend Stocks for June 2020.NEWS3: Dow flat despite losses for shares of Pfizer, Cisco.NEWS4: Why virus stocks are driving market volatility.NEWS5: U.S. awards new $628 mln contract to boost output of potential COVID-19 vaccine.

Answer: Rise